GLP-1 Side Effects: What Patients Should Know
A clinically grounded, honest overview of semaglutide and tirzepatide side effects — what’s common, what’s rare, and when to contact your provider.
Understanding GLP-1 Medication Side Effects
GLP-1 receptor agonists — including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — are among the most extensively studied weight loss medications in history. Like all prescription medications, they carry a risk of side effects. Understanding what to expect helps patients make informed decisions and recognize when to seek medical guidance.
The majority of patients who experience side effects report mild, temporary gastrointestinal symptoms that are most common during the dose escalation phase and typically improve as the body adjusts. Serious side effects are rare but important to understand before starting treatment.
This guide covers the full side effect profile of GLP-1 medications based on FDA prescribing information and published clinical trial data from the STEP (semaglutide) and SURMOUNT (tirzepatide) trial programs.
Common Side Effects of GLP-1 Medications
The following side effects were reported in clinical trials for both semaglutide and tirzepatide. They are typically mild to moderate in severity, dose-dependent, and most frequent during the first weeks of treatment or after a dose increase.
Gastrointestinal (Most Common)
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Abdominal pain or discomfort
- Bloating or gas
- Acid reflux / heartburn
- Decreased appetite (intended effect)
Other Commonly Reported
- Fatigue (particularly early in treatment)
- Headache
- Dizziness
- Injection site reactions (redness, itching, bruising)
- Burping
- Changes in taste
- Hair thinning (associated with rapid weight loss, not the medication directly)
💡 Tips for Managing Common GI Side Effects
- Eat smaller, slower meals — avoid large portions that stress the stomach
- Avoid high-fat, greasy, or spicy foods, especially early in treatment
- Stay well hydrated throughout the day
- Do not lie down immediately after eating
- Follow your physician’s dose escalation schedule — slower titration reduces GI burden
- Contact your provider if nausea or vomiting prevents adequate food or fluid intake
Serious Side Effects: What to Be Aware Of
Serious side effects from GLP-1 medications are uncommon but require prompt medical attention if they occur. The following are documented in FDA prescribing information for semaglutide and tirzepatide.
Pancreatitis
- Severe, persistent abdominal pain (often radiating to the back)
- Nausea and vomiting accompanying abdominal pain
- Discontinue medication and seek immediate medical care if suspected
- Patients with a history of pancreatitis should discuss risks with their physician
Gallbladder Disease
- Rapid weight loss can increase gallstone risk
- Symptoms: right upper abdominal pain, nausea, fever, jaundice
- GLP-1 medications may increase the risk of gallbladder-related events
- Report any gallbladder symptoms to your provider promptly
Hypoglycemia (Low Blood Sugar)
- More likely in patients also taking insulin or sulfonylureas
- Symptoms: shakiness, sweating, confusion, rapid heartbeat, hunger
- GLP-1 medications alone rarely cause hypoglycemia in non-diabetic patients
- Discuss all current medications with your physician before starting
Kidney Function Changes
- Severe GI side effects (vomiting, diarrhea) can cause dehydration
- Dehydration may worsen kidney function, particularly in patients with existing kidney disease
- Stay hydrated and report persistent GI symptoms to your provider
- Kidney function may be monitored in at-risk patients
⚠️ FDA Boxed Warning: Thyroid C-Cell Tumors
GLP-1 receptor agonists, including semaglutide and tirzepatide, carry an FDA boxed warning regarding thyroid C-cell tumors observed in animal studies. This risk has not been confirmed in humans, but these medications are contraindicated in patients with:
- A personal or family history of medullary thyroid carcinoma (MTC)
- A personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Patients should report any neck lump, hoarseness, difficulty swallowing, or shortness of breath to their physician immediately. A thorough physician evaluation screens for these contraindications before prescribing.
Other Rare but Documented Risks
- Heart rate increase: A small increase in resting heart rate has been observed in some patients
- Diabetic retinopathy complications: Reported in patients with pre-existing diabetic eye disease; discuss with your physician
- Allergic reactions: Rare; symptoms include rash, itching, swelling, difficulty breathing — seek emergency care immediately
- Suicidal ideation: FDA is monitoring reports; contact your provider immediately if you experience changes in mood or thoughts of self-harm
When to Contact Your Provider
Most side effects are manageable with physician guidance. Contact your prescribing provider if you experience any of the following:
- Nausea or vomiting that prevents you from eating or drinking adequately
- Diarrhea lasting more than a few days or causing significant dehydration
- Abdominal pain that is severe, persistent, or worsening
- Signs of low blood sugar (shakiness, sweating, confusion, rapid heartbeat)
- A lump or swelling in your neck, hoarseness, or difficulty swallowing
- Symptoms of gallbladder problems (right upper abdominal pain, fever, jaundice)
- Vision changes
- Significant injection site reactions that do not resolve
- Any side effect that significantly affects your daily functioning or quality of life
- Changes in mood, depression, or thoughts of self-harm
🚨 Seek Emergency Care Immediately For:
- Severe abdominal pain radiating to the back (possible pancreatitis)
- Signs of a serious allergic reaction: hives, swelling of face/lips/tongue/throat, difficulty breathing
- Symptoms of severe hypoglycemia: loss of consciousness, seizure
- Chest pain or signs of a cardiac event
How Physicians Monitor Patients on GLP-1 Medications
Responsible GLP-1 programs include ongoing physician monitoring — not just an initial prescription. At DietsMD, monitoring is built into every program. Here’s what physician oversight typically includes:
| What Is Monitored | Why It Matters | Frequency |
|---|---|---|
| Weight loss progress | Confirms medication is working; guides dose decisions | Monthly or per check-in |
| Side effect reporting | Identifies issues early; allows dose adjustment | Ongoing / as needed |
| Blood pressure & heart rate | GLP-1 medications may affect cardiovascular parameters | Periodic |
| Blood glucose (diabetic patients) | Prevents hypoglycemia, especially with other diabetes medications | As clinically indicated |
| Kidney function | Dehydration from GI side effects can affect renal function | As clinically indicated |
| Dose titration review | Gradual escalation reduces side effect burden | Per titration schedule |
| Medication interactions | Ensures safety with other prescriptions | At intake and ongoing |
What to Look for in a Monitoring Program
- Physician (MD/DO) involvement — not just automated check-ins
- Clear process for reporting side effects and receiving timely responses
- Dose titration guidance included in the program — not an add-on
- Access to your provider between scheduled check-ins if concerns arise
- Transparent documentation of your treatment plan and progress
Questions About GLP-1 Side Effects?
DietsMD board-certified physicians are available to review your health history, discuss your concerns, and determine whether semaglutide or tirzepatide is appropriate for you — with ongoing monitoring included in every program.
Start Your Consultation →Frequently Asked Questions
What are the most common side effects of GLP-1 medications?
The most common side effects are gastrointestinal: nausea, diarrhea, constipation, vomiting, and abdominal discomfort. These are typically mild, dose-dependent, and most common during the dose escalation phase. They often improve as the body adjusts to the medication.
Are GLP-1 side effects permanent?
For most patients, GLP-1 side effects are temporary and improve over time. Serious side effects are rare. If side effects are persistent or severe, contact your prescribing physician, who may adjust the dose or recommend a different approach.
Do semaglutide and tirzepatide have the same side effects?
Semaglutide and tirzepatide share a similar side effect profile, primarily gastrointestinal effects. Tirzepatide’s dual GIP/GLP-1 mechanism may produce a slightly different profile in some patients. Both carry the same serious risk warnings, including contraindication in patients with a history of MTC or MEN2. See our full Tirzepatide vs. Semaglutide comparison.
How can I reduce nausea from GLP-1 medications?
Nausea can often be reduced by eating smaller, slower meals; avoiding high-fat or spicy foods; staying hydrated; and not lying down immediately after eating. Gradual dose escalation under physician guidance is the most effective strategy for minimizing GI side effects.
When should I contact my doctor about GLP-1 side effects?
Contact your physician if you experience severe or persistent abdominal pain, signs of pancreatitis, symptoms of low blood sugar, vision changes, signs of allergic reaction, or any side effect that significantly affects your daily functioning. Seek emergency care for severe symptoms such as severe abdominal pain radiating to the back or signs of a serious allergic reaction.
Can GLP-1 medications cause thyroid cancer?
GLP-1 medications carry an FDA boxed warning regarding thyroid C-cell tumors based on animal studies. This risk has not been confirmed in humans, but these medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. A physician evaluation screens for these contraindications before prescribing.
How do physicians monitor patients on GLP-1 medications?
Physicians typically monitor weight loss progress, blood pressure, heart rate, blood sugar (in diabetic patients), kidney function, and reported side effects. Dose titration is adjusted based on patient response. DietsMD includes ongoing physician monitoring as part of every program.
Start a Physician-Guided GLP-1 Program with Ongoing Monitoring
DietsMD programs include board-certified MD oversight, dose titration guidance, and ongoing monitoring — so you’re never managing side effects alone. Fully online, all-inclusive pricing.
View DietsMD Programs →